Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment in Patients With Complicated S. Aureus Infection
Clinical trial NCT05655091 · RECRUITING
Trial details
- NCT number
- NCT05655091
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-26
- Primary completion
- 2025-12-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.